BioSpace News Archive

Humacyte, Inc. today announced that leadership will present new data and additional information on its programs at several scientific events in November 2021.

GT Biopharma, Inc. Appoints Dr. Gregory Berk, current President of R&D and Chief Medical Officer, as Interim Chief Executive Officer

Ichnos Sciences Inc. today announced the appointment of Eric J. Feldman , M.D., to the position of Chief Medical Officer (CMO), effective immediately.

Galmed Pharmaceuticals Ltd. provides today updated information on the Company’s scientific and clinical development programs and reports financial results for the three and nine months ended September 30, 2021.

Endo International plc (NASDAQ: ENDP) today announced that its Par Sterile Products business will supply VASOSTRICT ® , vasopressin injection, USP, vial presentations to healthcare providers through Premier’s Premier ProRx ® program

Precision BioSciences, Inc. today announced that Sam Wadsworth, Ph.D., Chief Scientific Officer of Ultragenyx Gene Therapy Shari Lisa Piré, J.D., Chief Legal & Sustainability Officer at Plume Design, have been appointed to the Company’s Board of Directors.

The global molecular diagnostics market is witnessing a significant growth since past few years.

Two major user propositions for deploying healthcare virtual assistants are their imprint on reducing the burden of care teams and improved patient experience.

Bacterial and viral collection is done in healthcare settings to diagnose the kind of disease an individual has.

Autolus Therapeutics plc and Blackstone Life Sciences announced that the two companies have entered into a strategic collaboration and financing agreement under which funds managed by Blackstone will provide up to $250 million in equity and product financing to support Autolus’ advancement of its CD19 CAR T cell investigational therapy product candidate, obecabtagene autoleucel, as well as next generation product therapies of obe-cel in B-cell malignancies.